In the same vein, Wu et al.’s study showed that increases in circulating MG53 were accompanied by increased BMI, hyperglycemia, and hyperinsulinemia in humans and rats with T2DM treated with an HFD (for 35 weeks) [16]. The gene discussed is TRIM72; the disease is type 2 diabetes mellitus.